Knoll Capital Management, LLC - 14 Nov 2024 Form 3 Insider Report for Entera Bio Ltd. (ENTX)

Role
10%+ Owner
Signature
/s/ Fred Knoll
Issuer symbol
ENTX
Transactions as of
14 Nov 2024
Net transactions value
$0
Form type
3
Filing time
20 Nov 2024, 13:53:33 UTC

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENTX Ordinary Shares, par value NIS 0.0000769 per share 5,534,275 14 Nov 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENTX Pre-funded warrant 14 Nov 2024 Ordinary Shares, par value NIS 0.0000769 per share 347,604 $0.000000 Direct
holding ENTX Warrants (right to buy) 14 Nov 2024 Ordinary Shares, par value NIS 0.0000769 per share 1,197,604 $1.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

* Gakasa beneficially owns 5,534,275 Shares of the Issuer's Common Stock and 347,604 pre-funded warrants. Each of KCM and Knoll beneficially own 5,534,275 Shares of the Issuer's Common Stock and 347,604 pre-funded warrants. KCM has trading authority for Gakasa, and Knoll is the President of KCM. KCM is a limited liability company formed and existing under the laws of the State of Florida. Knoll is a citizen of the United States. Gakasa is a limited liability company organized under the laws of the State of Florida.